Institutional Repository of Vilnius University
Elektroporacijos taikymas transfekcijoms in vitro ir vėžinių ląstelių žudymui in vivo /
Abstract
dc:descriptionIn our study, we used nanosecond and sub-microsecond electroporation as a promising method that could be applied for the transfection of mammalian cells and the development of anticancer therapy. The two-part study was performed in vitro and in vivo. In vitro, based on literature and experiments, a nanosecond electrotransfection protocol was developed using CHO-K1 cells. The GFP protein reporter system and flow cytometry method were used to determine transfection efficiency, and Alamar Blue fluorescence measurements were used to assess cell viability. We identified and optimized the conditions necessary for electrotransfection of mammalian (CHO-K1) cells: 0.162 million cells (6 million/ml cell suspension) were plated in a 48-well plate; 2 mg/ml DNA was purified with HiPure Expi plasmid Gigaprep Kit; the incubation time of samples was 20 min. before and 10 min. after the electroporation, and a glucose-based buffer solution with an increased concentration of Mg2+ was preferred. Optimal nanosecond electroporation PEF parameters (5 kV/cm × 300 × 250 / 1 MHz) were selected, which were equal or exceeded up to 1.5 times the electrotransfection efficiency and 1.3–1.6 times the cell viability obtained with microsecond control parameters (1.5 kV/cm × 100 µs × 4 / 1 Hz). These nanosecond electroporation pulse parameters could be applied in industry or biomedical sciences. In vivo, the efficacy of combined anticancer electrochemotherapy with different chemotherapeutic drugs was evaluated by using the C57BL/6J mouse LLC1 lung carcinoma model system. In the study, tumor volume and luminescence intensity were measured, afterwards, mouse survival was assessed. Electrochemotherapy with Bleomycin and Doxorubicin inhibited the development of carcinoma tumors and prolonged the survival of C57BL/6J mice. Sub-microsecond electrical pulses (1.6 kV/cm × 25 µs × 32 / 1 Hz) compared to microsecond pulses used in ESOPE protocols, had shorter duration and cause less necrosis of healthy tissues around the tumor and help to deliver chemotherapeutic drugs more locally to tumor cells. Therefore, sub-microsecond pulses were more sufficient for electroporation of tumors and in combination with chemotherapeutic agents could be applied for the development of combined anticancer treatment strategies.
Degree
thesis:*- Grantor dc:publisher
- Institutional Repository of Vilnius University
- Year dc:date
- 2020
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Balevičiūtė, Austėja,
Rights
dc:rights- Statement dc:rights
-
- info:eu-repo/semantics/openAccess
- Language dc:language
- lit
Identifiers
dc:identifier.*- Repository record dc:identifier
- https://repository.vu.lt/VU:ELABAETD193302250&prefLang=en_US